Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In vivo AAV-CRISPR/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia
The company states it does not accept insurance and describes this as enabling "transparent, direct-to-patient pricing without the complexities of insurance claims." According to the website, the company does not currently accept FSA or HSA cards for payment
The policy now is more tailored: doctors look at the patients health, the type of surgery, and any side effects from the drug
10.5650/jos.ess19303 53
Find out more from this WebMD slideshow
US$ 27.79
US$ 22.68
US$ 25.41
US$ 25.96
US$ 26.50
US$ 25.33
US$ 27.33
US$ 20.66
US$ 20.95
